# Feasibility Questionnaire Portfolio  

Feasibility assessments ensure that selected sites can safely and efficiently conduct the study.  

## Files  
- `FQ_Review_HRI_Noureddin.md` – Phase I site feasibility evaluation.  
- `FQ_Review_Synergy_Weston.md` – Phase I site feasibility evaluation.  
- `FQ_Template.md` – Generic feasibility review template.  
# Feasibility Review – HRI / PI: Dr. Noureddin  

**Strengths**:  
- PI with extensive hepatology experience (>20 NAFLD trials).  
- Dedicated CRC team and on-site FibroScan access.  

**Weaknesses**:  
- Limited prior Phase I exposure.  

**Decision**: Acceptable – Site meets patient recruitment and infrastructure requirements; Phase I oversight to be strengthened.  
# Feasibility Review – Synergy HC / PI: Dr. Weston  

**Strengths**:  
- Experienced with Phase I metabolic trials.  
- Access to genotype testing lab.  

**Weaknesses**:  
- Limited patient diversity pool.  

**Decision**: Acceptable – Strong operational setup; patient recruitment risk to be monitored.  
